Pre-Clinical Investigation of Anti-TFPI-Mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders
Convoca: Pfizer, Inc
Termini: 01/07/2026
Pre-Clinical Investigation of Anti-TFPI-Mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders
on 18 de maig de 2026
with No hi ha comentaris

Deixa un comentari